KYIV, Nov 19 – Biopharma, one of the first pharmaceutical companies to produce therapeutics to treat COVID-19, said its production of Bioven drug is limited due to lack of plasma donation culture in Ukraine.
Oksana Plotnikova, director of strategic development at Biopharma, called on people who recovered from coronavirus to donate plasma for help boost drug output.
|